Cancer and Postradiotherapy Cardiotoxicity: How to Face Damage in Women’s Hearts?

Cancer and cardiovascular disease are the two main causes of death worldwide in both men and women. In the past decades, survival rate in cancer patients has substantially improved due to new treatments and developments in radiation therapy (RT). In women, breast cancer (BC) is the leading cause of...

Full description

Bibliographic Details
Main Authors: Amalia Peix, Aylen Perez, Ana Maria Barreda
Format: Article
Language:English
Published: Radcliffe Medical Media 2023-03-01
Series:European Cardiology Review
Online Access:https://www.ecrjournal.com/articleindex/ecr.2022.36
Description
Summary:Cancer and cardiovascular disease are the two main causes of death worldwide in both men and women. In the past decades, survival rate in cancer patients has substantially improved due to new treatments and developments in radiation therapy (RT). In women, breast cancer (BC) is the leading cause of cancer death and thoracic RT is a main component of the treatment in many cases. Nevertheless, despite new techniques that limit the area receiving RT, cardiac damage is still an important concern in BC patients. In this review, the following aspects will be addressed: pathophysiology of postradiotherapy heart damage in women with BC; mechanisms, diagnosis and prevention/management of heart damage; and future areas of potential research for radiotherapy injury in women.
ISSN:1758-3756
1758-3764